215 related articles for article (PubMed ID: 18646007)
1. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures.
Miyoshi E; Nakano M
Proteomics; 2008 Aug; 8(16):3257-62. PubMed ID: 18646007
[TBL] [Abstract][Full Text] [Related]
2. Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells.
Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Nakagawa T; Matsumoto H; Asahi M; Koyama N; Miyoshi E
Biochem Biophys Res Commun; 2008 Dec; 377(3):792-6. PubMed ID: 18951869
[TBL] [Abstract][Full Text] [Related]
3. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.
Okuyama N; Ide Y; Nakano M; Nakagawa T; Yamanaka K; Moriwaki K; Murata K; Ohigashi H; Yokoyama S; Eguchi H; Ishikawa O; Ito T; Kato M; Kasahara A; Kawano S; Gu J; Taniguchi N; Miyoshi E
Int J Cancer; 2006 Jun; 118(11):2803-8. PubMed ID: 16385567
[TBL] [Abstract][Full Text] [Related]
4. Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.
Miyoshi E; Shinzaki S; Moriwaki K; Matsumoto H
Methods Enzymol; 2010; 478():153-64. PubMed ID: 20816478
[TBL] [Abstract][Full Text] [Related]
5. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
Matsumoto H; Shinzaki S; Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Kanke F; Satomura S; Kumada T; Miyoshi E
Clin Chem Lab Med; 2010 Apr; 48(4):505-12. PubMed ID: 20128732
[TBL] [Abstract][Full Text] [Related]
7. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer.
Takeda Y; Shinzaki S; Okudo K; Moriwaki K; Murata K; Miyoshi E
Cancer; 2012 Jun; 118(12):3036-43. PubMed ID: 22006099
[TBL] [Abstract][Full Text] [Related]
8. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
[TBL] [Abstract][Full Text] [Related]
10. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
11. Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.
Kamada Y; Kinoshita N; Tsuchiya Y; Kobayashi K; Fujii H; Terao N; Kamihagi K; Koyama N; Yamada S; Daigo Y; Nakamura Y; Taniguchi N; Miyoshi E
Clin Chim Acta; 2013 Feb; 417():48-53. PubMed ID: 23262369
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of oligosaccharide specificities of fucose-specific lectins from Aspergillus oryzae and Aleuria aurantia using frontal affinity chromatography.
Matsumura K; Higashida K; Hata Y; Kominami J; Nakamura-Tsuruta S; Hirabayashi J
Anal Biochem; 2009 Mar; 386(2):217-21. PubMed ID: 19109923
[TBL] [Abstract][Full Text] [Related]
13. Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116.
Kawasaki N; Lin CW; Inoue R; Khoo KH; Kawasaki N; Ma BY; Oka S; Ishiguro M; Sawada T; Ishida H; Hashimoto T; Kawasaki T
Glycobiology; 2009 Apr; 19(4):437-50. PubMed ID: 19129245
[TBL] [Abstract][Full Text] [Related]
14. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
Moriwaki K; Noda K; Nakagawa T; Asahi M; Yoshihara H; Taniguchi N; Hayashi N; Miyoshi E
Glycobiology; 2007 Dec; 17(12):1311-20. PubMed ID: 17884843
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
16. Biological function of fucosylation in cancer biology.
Miyoshi E; Moriwaki K; Nakagawa T
J Biochem; 2008 Jun; 143(6):725-9. PubMed ID: 18218651
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA system.
Kusama K; Okamoto Y; Saito K; Kasahara T; Murata T; Ueno Y; Kobayashi Y; Kamada Y; Miyoshi E
Glycoconj J; 2017 Aug; 34(4):537-544. PubMed ID: 28455724
[TBL] [Abstract][Full Text] [Related]
18. Structural determination by negative-ion MALDI-QIT-TOFMSn after pyrene derivatization of variously fucosylated oligosaccharides with branched decaose cores from human milk.
Amano J; Osanai M; Orita T; Sugahara D; Osumi K
Glycobiology; 2009 Jun; 19(6):601-14. PubMed ID: 19240274
[TBL] [Abstract][Full Text] [Related]
19. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.
Park SY; Yoon SJ; Jeong YT; Kim JM; Kim JY; Bernert B; Ullman T; Itzkowitz SH; Kim JH; Hakomori SI
Int J Cancer; 2010 Jan; 126(1):142-55. PubMed ID: 19551866
[TBL] [Abstract][Full Text] [Related]
20. α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers.
Park SY; Lee SH; Kawasaki N; Itoh S; Kang K; Hee Ryu S; Hashii N; Kim JM; Kim JY; Hoe Kim J
Int J Cancer; 2012 May; 130(10):2366-76. PubMed ID: 21780104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
